Overview

Lefamulin for M. Genitalium Treatment Failures

Status:
Not yet recruiting
Trial end date:
2022-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this drug study is to find out whether the antibiotic lefamulin (trade name Xenleta) will cure Mycoplasma genitalium infections that have not been cured by prior antibiotics while finding out whether it is more effective if the antibiotic doxycycline is taken first.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Washington
Collaborator:
Nabriva Therapeutics AG
Treatments:
Doxycycline
Lefamulin